This pill was initially sold under the name Rybelsus, but was rebranded as Ozempic in May 2026
Efficacy of two antibody-drug conjugates following single subcutaneous injections at three doses of 170, 340, and 680 g/kg in mouse models of human colon cancer using HCT-15, COLO 205 MDR, and COLO 205 cells
Analysis of this comparison revealed marked metabolic modulation in the treated tissue
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
Hypothyroidism can develop independently of Ozempic use and requires specific treatment with levothyroxine
Tirzepatide represents the latest advancement in medical weight loss medication